Published in Tob Control on March 01, 2003
Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95
The present and future burden of urinary bladder cancer in the world. World J Urol (2009) 4.56
WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ (2003) 3.42
Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12
Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Am J Public Health (2004) 1.87
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr (2011) 1.81
Policy lessons from comparing mortality from two global forces: international terrorism and tobacco. Global Health (2005) 1.51
Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control (2007) 1.49
Communicating risks at the population level: application of population impact numbers. BMJ (2003) 1.30
Tobacco attributable deaths in South Africa. Tob Control (2004) 1.30
The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control (2006) 1.18
Changes in smoking prevalence in 8 countries of the former Soviet Union between 2001 and 2010. Am J Public Health (2012) 1.15
Global Patterns and Determinants of Sex Differences in Smoking. Int J Comp Sociol (2006) 1.12
Smoking in Ghana: a review of tobacco industry activity. Tob Control (2009) 1.11
Estimating smoking-attributable mortality in the United States. Demography (2012) 1.06
A prospective study of tobacco smoking and mortality in Bangladesh. PLoS One (2013) 0.99
Cross-national sources of health inequality: education and tobacco use in the World Health Survey. Demography (2011) 0.98
Knowledge of the health impacts of smoking and public attitudes towards tobacco control in the former Soviet Union. Tob Control (2012) 0.97
Prevalence and correlates of tobacco use among a sample of MSM in Shanghai, China. Nicotine Tob Res (2010) 0.96
Methodologies used to estimate tobacco-attributable mortality: a review. BMC Public Health (2008) 0.92
Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts. BMC Cancer (2008) 0.91
Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart (2012) 0.89
National Income, Inequality and Global Patterns of Cigarette Use. Soc Forces (2007) 0.83
Smoking-attributable mortality in Morocco: results of a prevalence-based study in Casablanca. Arch Public Health (2014) 0.82
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Pollutional haze as a potential cause of lung cancer. J Thorac Dis (2015) 0.80
Widening Life Expectancy Advantage of Hispanics in the United States: 1990-2010. J Immigr Minor Health (2015) 0.78
The enduring effects of smoking in Latin America. Am J Public Health (2015) 0.77
Mortality attributable to tobacco: review of different methods. Arch Public Health (2014) 0.77
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Tob Control (2007) 0.77
Risks for tuberculosis in Kazakhstan: implications for prevention. Int J Tuberc Lung Dis (2017) 0.75
A cross-sectional study examining youth smoking rates and correlates in Tbilisi, Georgia. Biomed Res Int (2014) 0.75
Lung Cancer Risk and Residential Exposure to Air Pollution: A Korean Population-Based Case-Control Study. Yonsei Med J (2017) 0.75
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA (2002) 28.72
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ (1997) 8.05
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ (1997) 7.37
Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ (2000) 6.22
Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health (1995) 4.60
Urban air pollution and lung cancer in Stockholm. Epidemiology (2000) 4.50
Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health (2002) 4.22
Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst (2002) 3.45
Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA (2000) 3.21
A case-control study of lung cancer with special reference to the effect of air pollution in Poland. J Epidemiol Community Health (1990) 1.87
Air pollution as a risk factor in lung cancer. Am J Epidemiol (1982) 1.62
Atmospheric pollution and lung cancer. Environ Health Perspect (1978) 1.60
Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann N Y Acad Sci (1990) 1.56
Estimating census and death registration completeness. Asian Pac Popul Forum (1987) 1.53
The international comparability of cancer mortality data. Results of an international death certificate study. Am J Epidemiol (1989) 1.30
Estimating mortality due to cigarette smoking: two methods, same result. Epidemiology (2000) 1.28
Quantitative relationship between cumulative cigarette consumption and lung cancer mortality in Japan. Int J Epidemiol (2000) 1.09
Mortality estimation from registered deaths in less developed countries. Demography (1984) 1.06
An epidemiological study of risk factors for lung cancer in Guangzhou, China. Lung Cancer (1996) 1.00
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
Armed conflict as a public health problem. BMJ (2002) 4.42
Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31
On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66
The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46
Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37
Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17
The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84
The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49
Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12
Measuring the burden of disease. Lancet (1998) 1.58
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Hypertension in developing countries. World Health Stat Q (1988) 1.45
Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35
Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33
Tobacco or health. World Health Stat Q (1993) 1.32
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19
Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
On the assessment of maternal mortality. World Health Stat Q (1987) 1.04
A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02
Sex differentials in mortality. WHO Chron (1984) 1.02
Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00
Reducing child mortality. Bull World Health Organ (2000) 0.94
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92
Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91
Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89
Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88
Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86
Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85
Smoking and death in Russia. Tob Control (1998) 0.84
Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83
A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83
Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81
The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81
Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80
Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80
100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79
Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79
Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78
Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78
Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78
Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77
Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77
Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76
In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76
Investigating Australia's burden of disease. Med J Aust (2000) 0.75
Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75
Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75
Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75
[Preventable deaths: general view]. World Health Stat Q (1989) 0.75
Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75
Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75
Health projections. Introduction. World Health Stat Q (1984) 0.75
The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75